A Gene-Based Aesthetics Company

Learn More
Not an actual patient
INNOVATIVE AND DIFFERENTIATED APPROACH ADDRESSES UNDERLYING BIOLOGY CLINICALLY VALIDATED TECHNOLOGY

About Us

Jeune Inc. is a biotechnology company leveraging a clinically validated gene-delivery platform to fundamentally address – and reverse – the biology of aging or photo-damaged skin.
Jeune was formed in April 2019 by Krystal Biotech to advance a portfolio of innovative treatments that address aesthetic skin conditions. Product candidates are based on Krystal’s validated gene delivery platform. This skin-optimized gene delivery technology enables us to specifically target key cells in the skin for the delivery of a desired effector (gene). In doing so, we aim to stimulate a patient’s own cells to produce the important structural proteins that normally decline over time as we age (intrinsic aging) and with photo-damage (extrinsic aging).
Learn More

Our Science

Changes in the amount and organization of important proteins, like collagen and elastin, are the primary factor in the appearance of aging or damaged skin.
Jeune’s pipeline of innovative treatments are designed to directly address the biology of aging skin by stimulating a patient’s own cells to produce the proteins that keep skin looking younger and healthier.
scientist holding a beaker

Our Pipeline

Program
Indication
Gene
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Commercial
KB301
TBD
type III collagen
KB302
TBD
type I collagen
KB303
TBD
elastin
KB304
TBD
type III collagen + elastin
KB305
TBD
type IV collagen

Jeune Team

News

Contact Us

Thanks for contacting us! We will get in touch with you shortly.

Contact Us

Contact Us


Top